VYGR: Form 144 for 3,301 Common Shares

Voyager Therapeutics submitted a Form 144 notice disclosing a proposed sale of 3,301 common shares.

Rhea-AI Filing Summary

Voyager Therapeutics submitted a Form 144 notice disclosing a proposed sale of 3,301 common shares. The filing identifies the shares as Restricted Stock Vesting tied to compensation with a vesting date of 02/17/2026. The filing also records a prior sale by Todd Carter of 3,525 common shares on 02/10/2026. The Form lists 02/18/2026 and notes the securities trade on NASDAQ.

Insights

Securities Compliance Analyst

Routine Form 144 shows proposed resale following restricted stock vesting and a recent insider sale.

The filing lists a proposed sale of 3,301 shares of common stock described as Restricted Stock Vesting with a vesting date of 02/17/2026, and a prior sale of 3,525 shares on 02/10/2026.

Such notices typically document planned dispositions under resale rules; the actual timing and execution depend on holder decisions and market arrangements. Subsequent filings or broker reports would show completed transactions and proceeds if executed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the VYGR Form 144 disclose?

The Form 144 discloses a proposed sale of 3,301 common shares tied to restricted stock vesting on 02/17/2026. It also records a prior sale of 3,525 shares by Todd Carter on 02/10/2026, and lists NASDAQ.

Who is the reported seller in the VYGR filing?

The filing identifies Todd Carter as the person associated with the prior sale of 3,525 shares on 02/10/2026. The proposed sale of 3,301 shares is linked to restricted stock vesting and compensation dated 02/17/2026.

What type of shares are being offered in the VYGR Form 144?

The shares to be sold are described as Restricted Stock Vesting issued as compensation with a vesting date of 02/17/2026. The filing lists the quantity as 3,301 common shares to be offered.

When were the prior reported sales for VYGR executed?

The previously reported sale in the excerpt shows 3,525 common shares sold on 02/10/2026 by Todd Carter. This sale is listed under 'Securities Sold During The Past 3 Months' in the filing.

Does the Form 144 show where VYGR securities trade?

Yes; the filing entry includes NASDAQ as the market where the common securities trade. The Form lists the filing date as 02/18/2026 alongside the exchange designation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 03:50 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001944011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Voyager Therapeutics, Inc.
SEC File Number	001-37625
Address of Issuer	75 HAYDEN AVENUE LEXINGTON MASSACHUSETTS 02421
Phone	857-259-5340
Name of Person for Whose Account the Securities are To Be Sold	Carter Todd Alfred
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3301	11345.54	55600084	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			3301	02/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Todd Carter 75 Hayden Avenue Lexington MA 02421	Common	02/10/2026	3525	13552.57

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Todd Carter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)